Women in the U.K. with non–screen-detected ductal carcinoma in situ had a fourfold higher risk for invasive breast cancer and for breast cancer death than the general population.
Recommendations for mammography intervals following a diagnosis of ductal carcinoma in situ (DCIS) vary by country. In the U.S., mammography is recommended annually, so long as nothing of concern is identified that would warrant a shorter interval. In the U.K., the National Health Service (NHS) recommends annual mammograms for the first 5 years and then, for those aged 50–70, every 3 years until age 70. A question with longer intervals is whether invasive cancers may go undetected between mammograms and affect survival.
Investigators evaluated risk for invasive cancer in >27,000 women in England diagnosed with DCIS outside the NHS screening program from 1990 to 2018. Of these, 3651 women eventually were diagnosed with invasive breast cancer;…
Reviewing Author
DisclosuresConsultant/Advisory BoardLilly; AstraZeneca; Gilead
Grant/Research SupportBreast Cancer Research Foundation
Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment
Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)
DisclosuresConsultant/Advisory BoardLilly; AstraZeneca; Gilead
Grant/Research SupportBreast Cancer Research Foundation
Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment
Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)